Healthcare resource usage of schizophrenia patients initiating long-acting injectable antipsychotics vs oral.

Journal of medical economics

Volumn 16, Issue 2, 2013, Pages 231-239

  Offord, Steve ^a   Wong, Bruce ^b   Mirski, Dario ^b   Baker, Ross A ^b   Lin, Jay ^b  

^a OTSUKA PHARMACEUTICAL DEVELOPMENT AND COMMERCIALIZATION INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; DELAYED RELEASE FORMULATION; FEMALE; HEALTH CARE PLANNING; HOSPITALIZATION; HUMAN; INTRAVENOUS ADMINISTRATION; MALE; MIDDLE AGED; ORAL DRUG ADMINISTRATION; RECURRENT DISEASE; RETROSPECTIVE STUDY; SCHIZOPHRENIA; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; DELAYED-ACTION PREPARATIONS; FEMALE; HEALTH RESOURCES; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; RECURRENCE; RETROSPECTIVE STUDIES; SCHIZOPHRENIA; UNITED STATES; YOUNG ADULT;

EID: 84877978630     PISSN: None     EISSN: 1941837X     Source Type: None    
DOI: 10.3111/13696998.2012.751025     Document Type: Article

References (0)